SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook Post ContentsophRead More You might also be interested in reading Fomo overtakes Pump.fun in daily revenue on Solana. August 6, 2025 In Mainstream ← Previous post Next post →